SeaCrest Wealth Management LLC Has $2.18 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

SeaCrest Wealth Management LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 26.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,415 shares of the healthcare conglomerate’s stock after acquiring an additional 935 shares during the quarter. SeaCrest Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,184,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Richelieu Gestion SA acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. CGC Financial Services LLC boosted its holdings in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the last quarter. True Wealth Design LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $31,000. LFA Lugano Financial Advisors SA boosted its holdings in UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 40 shares during the last quarter. Finally, Transcendent Capital Group LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.7 %

Shares of UnitedHealth Group stock opened at $498.13 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The firm has a market cap of $458.47 billion, a PE ratio of 30.45, a P/E/G ratio of 1.48 and a beta of 0.60. The stock has a fifty day moving average price of $498.40 and a 200-day moving average price of $501.35. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same quarter last year, the firm posted $6.26 EPS. The firm’s revenue for the quarter was up 8.6% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were issued a dividend of $2.10 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.69%. UnitedHealth Group’s payout ratio is presently 51.34%.

Analysts Set New Price Targets

UNH has been the topic of several analyst reports. Royal Bank of Canada reduced their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday, April 17th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday, June 28th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price target on the stock in a report on Wednesday, June 5th. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Finally, Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.